2Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:828
8Sharms SK,Balamurugan A,Saha PK.et al.Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment[J].Am J Respir Crit Care Med,2002,166(7):916-919.
9Teleman MD,Chee CBE,Earnest A.et al.Hepatotoxicity of tuberculosis chemotherapy under general programme conditions in Singapore[J].Int Tuberc Lung Dis,2002,6(8):699-705.
10American Thoracic Society/Centers For Disease Control and Prevention (ATS/CDC).Executive Committee,Update:Fatal and Severe Liver Injuries Associated With Rifampin and Pyrazinamide for Latent Tuberculosis Infection,and Revisions in American Thoracic Society/CDC Recommendations-United States,2001[J].Am J Respir Crit Care Med,2001,164(7):1319-1320.